No Data
No Data
MediKey (688079.SH): The company's Third-generation Semiconductors packaging and testing has achieved small-scale production.
On December 18, Gelonghui reported that Meidikai (688079.SH) stated on the investor interaction platform that the construction project for an annual production of 2 billion semiconductor devices by Meidikai Microelectronics and the semiconductor wafer manufacturing and packaging project by Meidikai Optical Semiconductors are progressing as planned; the company's RF chips are mainly produced for design companies, where Normal SAW, TC-SAW, and TF-SAW have all achieved mass production, including wafer manufacturing and packaging testing; the BAW project resonator collection has been completed, and the full-process sample trial has begun; the company's Third-generation Semiconductors packaging has achieved small batch production.
Medike (688079.SH): The company's first-generation meta-surface device products, which are manufactured for others, have applications in service Siasun Robot&Automation and other areas.
On December 18, Gelonghui reported that Meidikai (688079.SH) stated on the investor interaction platform that the Glass wafers for Semiconductors produced by the company have fully entered mass production; the first generation of super-structured surface devices that the company manufactures has applications in service Siasun Robot&Automation and others.
Medike (688079.SH): The chip products under development can be used in the ai siasun robot&automation field.
On December 10, Gelonghui reported that Medica (688079.SH) stated on the investor interactive platform that the company has chip products under development for the ai siasun robot&automation field, which have not yet entered mass production.
MediKey (688079.SH): The cumulative change in Shengsheng Jiamei Co., Ltd. has reached 1.0735%.
Gelonghui, December 9th | MediKay (688079.SH) announced that it has received a notification from its shareholder Fengsheng Jiamei regarding a shareholding change exceeding 1%, Fengsheng Jiamei reduced its shares by 1,043,017 shares through block trade on July 6, 2023; from November 21, 2024 to December 6, 2024, it reduced its shares by 3,265,388 shares through centralized bidding trading method, with a cumulative shareholding change ratio of 1.0735%. After this equity change, shareholder Fengsheng Jiamei holds 33,638,236 shares of the company, still being a shareholder of the company.
Meidi Technology (688079.SH): The complete acoustic layer solution for the ultrasonic under-display fingerprint recognition chip has achieved mass production.
On December 2, Glory reports that Mediatek (688079.SH) stated on the investor interaction platform that the company's ultrasonic under-screen fingerprint recognition chip complete acoustic layer solution has achieved mass production. For specific related information, please pay attention to the periodic reports published by the company.
Medikey (688079.SH): The RF chip BAW project, multi-channel chromatographic chip optical path layer and other products are under development and testing, and the full process of sample preparation has been achieved.
On November 25th, Gelonghui reported that Medike (688079.SH) stated on the investor interaction platform that since its listing, the company has been committed to enriching and perfecting its business structure. Based on its existing optical products, it has placed significant investments in fields such as semiconductor acousto-optics, semiconductor micro-nano circuits, semiconductor packaging and testing, and micro-nano optics. Currently, products such as the complete acoustic layer solution for ultrasonic fingerprint chips, the complete optical path solution for ambient light chip products, the complete optical path solution for CIS image sensors, and the wafer manufacturing and packaging for RF chip SAW have gradually achieved mass production. Additionally, projects for RF chip BAW and multi-channel color...
No Data